Angelo Gordon & Co’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Angelo Gordon & Co’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,000	Closed	-$1.88M	–	310
2022 Q2	$1.88M	Buy	+25,000	New	+$1.11M	0.21%	66

Angelo Gordon & Co's TPTX Position: Q3 2022 in Review

Angelo Gordon & Co sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 25,000 shares — an estimated $1.88M sold.

Angelo Gordon & Co first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $1.88M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Angelo Gordon & Co reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Angelo Gordon & Co sold 25,000 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.88M.
Angelo Gordon & Co first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Angelo Gordon & Co's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.88M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Angelo Gordon & Co's 13F filing for Q3 2022, filed 14 Nov 2022.